Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.

Literature DB >> 10995419

Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.

D Skudicky¹, K Sliwa, A Bergemann, G Candy, P Sareli.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2000 PMID： 10995419 PMCID： PMC1729442 DOI： 10.1136/heart.84.4.438

Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994

× No keyword cloud information.

17 in total

Review 1. Antiarrhythmics--from cell to clinic: past, present, and future.

Authors: J C Hancox; K C Patel; J V Jones
Journal: Heart Date: 2000-07 Impact factor: 5.994

2. Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarction.

Authors: J T Walsh; P D Batin; M Hawkins; D McEntegart; A J Cowley
Journal: Heart Date: 1999-01 Impact factor: 5.994

3. Effect of pentoxifylline on apoptosis of cultured cells.

Authors: F Belloc; C Jaloustre; P Dumain; F Lacombe; M Lenoble; M R Boisseau
Journal: J Cardiovasc Pharmacol Date: 1995 Impact factor: 3.105

4. TNF-induced cardiomyopathy.

Authors: S Hegewisch; H J Weh; D K Hossfeld
Journal: Lancet Date: 1990-02-03 Impact factor: 79.321

5. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Authors: T Suda; T Takahashi; P Golstein; S Nagata
Journal: Cell Date: 1993-12-17 Impact factor: 41.582

6. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

Authors: N C Davidson; A A Naas; J K Hanson; N S Kennedy; W J Coutie; A D Struthers
Journal: Am J Cardiol Date: 1996-04-15 Impact factor: 2.778

7. Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure.

Authors: C M O'Connor; P A Gurbel; V L Serebruany
Journal: Am J Cardiol Date: 1999-05-01 Impact factor: 2.778

8. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Authors: J D Morrow; K E Hill; R F Burk; T M Nammour; K F Badr; L J Roberts
Journal: Proc Natl Acad Sci U S A Date: 1990-12 Impact factor: 11.205

9. Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995.

Authors: R O Netzer; E Zollinger; C Seiler; A Cerny
Journal: Heart Date: 2000-07 Impact factor: 5.994

10. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure.

Authors: J Nourooz-Zadeh; N K Gopaul; S Barrow; A I Mallet; E E Anggård
Journal: J Chromatogr B Biomed Appl Date: 1995-05-19

13 in total

Review 9. Heart failure in sub-Saharan Africa.

Authors: Gerald S Bloomfield; Felix A Barasa; Jacob A Doll; Eric J Velazquez
Journal: Curr Cardiol Rev Date: 2013-05

Review 10. Cardiomyopathies and myocardial disorders in Africa: present status and the way forward.

Authors: A O Falase; O S Ogah
Journal: Cardiovasc J Afr Date: 2012-11 Impact factor: 1.167

Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.

Review 1. Antiarrhythmics--from cell to clinic: past, present, and future.

2. Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarction.

3. Effect of pentoxifylline on apoptosis of cultured cells.

4. TNF-induced cardiomyopathy.

5. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

6. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

7. Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure.

8. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

9. Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995.

10. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure.

Review 1. Innate immunity and the failing heart: the cytokine hypothesis revisited.

2. Myocardial Fas and cytokine expression in end-stage heart failure: impact of LVAD support.

Review 3. Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.

4. Anthracycline-induced cardiomyopathy in a dog treated with epirubicin.

Review 5. Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis.

Review 6. Nutritional and anti-inflammatory interventions in chronic heart failure.

Review 7. Immunological mechanisms of pentoxifylline in chronic heart failure.

8. Allopurinol reduces antigen-specific and polyclonal activation of human T cells.

Review 9. Heart failure in sub-Saharan Africa.

Review 10. Cardiomyopathies and myocardial disorders in Africa: present status and the way forward.